Core B: Gene Modulation with RNAi and CRISPER
核心 B:利用 RNAi 和 CRISPER 进行基因调控
基本信息
- 批准号:10330429
- 负责人:
- 金额:$ 41.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-02-10 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Algorithm DesignAnimalsAntineoplastic AgentsAreaBiologicalBiological AssayBloodBreastCRISPR libraryCRISPR screenCRISPR/Cas technologyCell LineCellsCloningClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsCommunitiesComputational algorithmCultured CellsCustomDependenceDevelopmentDrug TargetingEnsureExposure toExpression LibraryFamilyFundingGene SilencingGenerationsGenesGeneticGuide RNAHumanLaboratoriesLibrariesLightLiverMalignant NeoplasmsMammalian CellMediatingMethodologyMethodsMolecularMusMutagenesisMutationNCI Center for Cancer ResearchPerformancePhosphotransferasesProceduresProteinsRNA InterferenceRNA libraryRNAi vectorResearch PersonnelScanningServicesStructureSystemTechniquesTechnologyTertiary Protein StructureTherapeuticTumor Suppressor GenesUntranslated RNAValidationWorkbasecancer celldesignexperimental studyexpression vectorfunctional genomicsgene functiongenetic analysisgenome editinggenome-wideimprovedin vivoinnovationinsertion/deletion mutationinterestknock-downmeetingsmembernovelprediction algorithmprogramsresponsescaffoldscreeningsensorsmall hairpin RNAtechnology developmenttherapeutic targettooltumortumor initiationvector
项目摘要
PROJECT SUMMARY-CORE B
Core B supports every project within the Program by providing access to state-of-the-art CRISPR-Cas9 and
RNAi tools. Short hairpin RNAs (shRNAs) were developed with the support of this program, and ongoing
innovations by Core B and Program investigators have helped to make these extremely powerful biological
tools. During the past funding period, the Core devised a novel algorithm for predicting shRNA potency, which
led to the generation of a 5th version of RNAi libraries corresponding to annotated protein coding genes in
humans and mice. Technology has also been developed for using CRISPR-Cas9 screening to expose
functionally important protein domains. During the upcoming period of requested support, the Core proposes to
aid Program investigators through five general aims. First, the program will continue providing access to state-
of-the-art RNAi vectors and CRISPR-Cas9 vectors and procedures for analyzing either single gene
knockdowns or for performing pooled RNAi/CRISPR screens. Second, the Core will provide Program
investigators with access to the mouse and human version 5 shRNA library and will compile sub-libraries upon
request. Third, the Core will construct custom CRISPR-scanning libraries for performing structure-function
analysis on genes of interest within each Program. Fourth, the Core will produce custom domain-focused
CRISPR libraries to allow for interrogation and discovery cancer drug targets in various contexts. Fifth, the
Core will carry on its efforts to improve CRISPR-Cas9 technologies, and make those innovations available to
the Program and to the scientific community at large.
项目总结-核心B
核心B通过提供最先进的CRISPR-Cas9和
RNAi工具。短发夹RNA(shRNAs)是在该项目的支持下开发的,
核心B和计划研究人员的创新有助于使这些极其强大的生物学
工具.在过去的资助期间,Core设计了一种预测shRNA效力的新算法,
导致了对应于注释的蛋白质编码基因的第五版RNAi文库的产生,
人类和老鼠还开发了使用CRISPR-Cas9筛选的技术,以暴露
功能重要的蛋白质结构域。在即将到来的请求支助期间,核心小组建议:
通过五个总体目标帮助项目调查人员。首先,该计划将继续提供访问状态-
现有技术的RNAi载体和CRISPR-Cas9载体以及用于分析任一单基因的方法
敲低或用于进行合并的RNAi/CRISPR筛选。第二,核心将提供方案
研究人员可以访问小鼠和人类版本5 shRNA文库,并将在
请求过程中第三,Core将构建定制的CRISPR扫描库,用于执行结构-功能分析。
分析每个程序中的感兴趣基因。第四,核心将产生定制领域为重点
CRISPR文库允许在各种情况下询问和发现癌症药物靶标。五是
Core将继续努力改进CRISPR-Cas9技术,并将这些创新技术提供给
该计划和整个科学界。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER VAKOC其他文献
CHRISTOPHER VAKOC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER VAKOC', 18)}}的其他基金
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
阐明 SCP4 通路作为急性髓系白血病的多催化信号传导依赖性
- 批准号:
10753227 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
在小细胞肺癌簇细胞变体中利用 POU2F3 成瘾
- 批准号:
10221648 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
在小细胞肺癌簇细胞变体中利用 POU2F3 成瘾
- 批准号:
9980811 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Targeting aberrant enhancer landscapes in pancreatic cancer
靶向胰腺癌中的异常增强子景观
- 批准号:
10199961 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
在小细胞肺癌簇细胞变体中利用 POU2F3 成瘾
- 批准号:
10693821 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Targeting aberrant enhancer landscapes in pancreatic cancer
靶向胰腺癌中的异常增强子景观
- 批准号:
9816984 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Elucidating the function of PAX3-FOXO1 in rhabdomyosarcoma with molecular reporters and next-generation genome editing
利用分子报告基因和下一代基因组编辑阐明 PAX3-FOXO1 在横纹肌肉瘤中的功能
- 批准号:
10064134 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
在小细胞肺癌簇细胞变体中利用 POU2F3 成瘾
- 批准号:
10450100 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Targeting aberrant enhancer landscapes in pancreatic cancer
靶向胰腺癌中的异常增强子景观
- 批准号:
10436243 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
Targeting aberrant enhancer landscapes in pancreatic cancer
靶向胰腺癌中的异常增强子景观
- 批准号:
10661753 - 财政年份:2019
- 资助金额:
$ 41.82万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 41.82万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 41.82万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 41.82万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 41.82万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 41.82万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




